Amgen
The Executive Medical Director, Early Development – Inflammation at Amgen leads the development of Inflammation programs, translating strategies into clinical study designs, and ensuring scientific rigor. They collaborate with cross-functional teams and regulatory agencies to advance molecules to medicines.
Headquarters
Thousand Oaks, California, United States
Company Size
10001+ employees
Founded
1980
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amgen.
116% above the average for this role
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
1 day ago
Executive Medical Director, Early Dev - Inflammation
lifelancer
Associate Medical Director, Clinical Science, GI2 TAU- Nephrology
Takeda Pharmaceutical Company Limited
Executive Medical Director, Global Safety, Hematology/Oncology
lifelancer
Clinical Research Medical Director - Oncology
lifelancer
Executive Medical Director, Global Safety, Hematology/Oncology
lifelancer
Senior Scientist, In Vivo Pharmacology, Inflammation Research (Respiratory
lifelancer